Lung Transplantation for Chronic Obstructive Pulmonary Disease

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Chronic Obstructive Pulmonary Disease is the leading cause of death amongst chronic respiratory diseases. Because of its protracted course, COPD is the most important contributor to the number of years lived with disability. Over the last 40years lung transplantation has emerged as the predominant surgical treatment for patients with end stage respiratory diseases. The interplay of variable lung function decline, comorbidities and overlap with other respiratory diseases hinder easy selection of COPD candidates for transplantation. Post-transplantation, perioperative mortality continues to decrease but chronic allograft dysfunction, infections and complications of immunossupresive regimens continue to be major barriers to long term survival.

Original languageEnglish
Title of host publicationEncyclopedia of Respiratory Medicine, Second Edition
PublisherElsevier
Pages676-685
Number of pages10
Volume5
ISBN (Electronic)9780081027240
ISBN (Print)9780081027233
DOIs
StatePublished - Jan 1 2021

Keywords

  • Alpha-1 antitrypsin deficiency
  • Chronic obstructive pulmonary disease
  • Comorbidities
  • Emphysema
  • Health related quality of life
  • Lung transplantation

Fingerprint

Dive into the research topics of 'Lung Transplantation for Chronic Obstructive Pulmonary Disease'. Together they form a unique fingerprint.

Cite this